Previous Events
A chronological record of talks, posters, workshops and conference contributions.
Neutrophil 2024
Prof Jesmond Dalli presented a poster entitled: Identifying neutrophil-derived molecular cues directing innate responses during bacterial infections
7th European Congress of Immunology
Prof Jesmond Dalli co-chaired the Resolution of Inflammation session
International Vascular Biology Meeting 2024
Prof Jesmond Dalli presented a poster entitled: Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease in inflammatory arthritis
9th European Workshop on Lipid Mediators
Dr Duco Koenis presented a poster entitled: Efferocyte-derived MCTRs prime macrophages for continual efferocytosis via Rac1-mediated activation of glycolysis
EFIS-iiSIAR forum Poznan.
Prof Jesmond Dalli presented a talk entitled: MCTRs Regulate Macrophage Pro-resolving and Tissue Reparative Functions
EpiLipidNet Meeting Dresden
Prof Jesmond Dalli presented a talk entitled: A Frameshift Variant in the Maresin 1 Receptor LGR6 Alters Human Phagocyte Responses and Increases Disease Incidence Ms Amitis Saliani presented a poster entitled: Evaluation of different integration and signal to noise algorithms on lipid mediator identification Mr Matthew Dooley presented a poster entitled: Development and validation of a high sensitivity method for the identification and quantitation of specialized pro-resolving mediators and classical eicosanoids.
1st EFIS forum on innate immunity in Sterile Inflammation, Autoimmunity, and their Resolution
Prof Jesmond Dalli presented a talk entitled: Utilizing Pro-Resolving Pathways for Treating Co-Morbidities 20th-23rd of March 2024 2024 European Phagocyte Workshop Prof Jesmond Dalli presented a talk entitled: Apoptotic cell uptake triggers localized MCTR production by macrophages to drive efferocytosis and tissue repair Dr Esteban Gomez presented a talk entitled: A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
CARIM Cardiovascular researcht institute & Maastricht University/University Medical Centre
Prof Jesmond Dalli presented a talk for Cardiovascular Grand Rounds entitled: Resolving cardiovascular diseases – what is the evidence?
Second Meeting of the UK Neutrophil Network
Prof Jesmond Dalli attended the meeting
3rd Resolution Days
Prof Jesmond Dalli presented Insights Into The Biology Of Specialized Pro-resolving Mediators And Their Receptors In Phagocytes Mr Esteban Gomez presented A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
BIORSP_2023
Prof Jesmond Dalli presented SPM are functional biomarkers for omega-3 supplements
10th Cardiovascular Research Days & 28th Krakow Conference on Endothelium
Prof Jesmond Dalli presented N-3 Docosapentaenoic Acid Resolvins In Vascular Protection
Bioactive Lipids in Cancer, Inflammation and Related Diseases 2022
Prof Jesmond Dalli presented Promoting tissue repair by reprogramming immune cells Mr Esteban A Gomez presented Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes Ms Roberta De Matteis presented Aspirin Triggered Specialised Pro-Resolving lipid mediators reprogram T cell and macrophage responses in colitis-associated colorectal cancer 9th – 12th of June 2022 31st Nordic Lipidforum Symposium 2022 Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
2022 AOCS Annual Meeting & Expo
Prof Jesmond Dalli presented Structure elucidation and biological evaluations of sulfido-conjugated specialized pro-resolving mediators
10th International Singapore Lipid Symposium
Prof Jesmond Dalli presented Structure elucidation and biological evaluations of n-3 docosapentaenoic acid-derived 13-series Resolvins February 2022 GOED Exchange Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
Ambiotis 15th Anniversary Celebrations
Professor Jesmond Dalli presenting Reprogramming Immune Cells as a Novel Therapeutic Approach
Turkish Pharmacology Society meeting
Professor Jesmond Dalli presenting Resolution of pathways as a novel therapeutic targets in cardiovascular diseases
Lipid Mediators in Brain Diseases Symposium, Hasselt, Belgium
Professor Jesmond Dalli presenting Specialised pro-resolving mediators as modulators of innate and adaptive immunity
ICBL Webinar – Lipid Mediators in Inflammation
Professor Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
ICBL Webinar – Lipid Mediators in InflammationExperimental Biology 2021
Professor Jesmond Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
The London Metabolomics Network Autumn meeting
Professor Jesmond Dalli presenting Establishing a role for immunoresolvents in the maintenance of homeostasis and as diagnostic markers in patient stratification
The London Metabolomics Network Autumn meetingBioactive Lipids in Cancer, Inflammation and Related Diseases 16th International Conference, St. Petersburg, Florida
Professor Jesmond Dalli presenting Insights mechanisms elicited by immunoresolvants in the maintenance of homeostasis and the termination of inflammation, Tuesday 22 October Dr Romain Colas presenting Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis, Monday 21 October Mr Issa Beegun presenting Maresin 1 regulates peripheral leukocyte responses in patients with chronic eosinophilic nasal polyposis, Monday 21 October Ms Roberta De Matteis presenting Pro-resolving mediators mediate the protective actions of aspirin in colitis associated colorectal cancer, Monday 21 October Dr Patricia Soares De Souza presenting Enriched marine oil supplements increase peripheral blood SPM concentrations and reprogram host immune responses: A randomized double-blind placebo-controlled study, Monday 21 October Mr Esteban Gomez Cifuentes presenting Identification of pro-resolving mediators-based predictive biomarkers to DMARD responsiveness in rheumatoid arthritis, Monday 21 October Dr Duco Koenis presenting RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections, Tuesday 22 October Dr Lucy Ly presenting MCTR1, MCTR2, and MCTR3 resolve inflammation and protect joints in Inflammatory Arthritis, Monday 21 October 30 September – 2 October 2019 15th GERLI international Lipidomics meeting, Compiègne, France
Bioactive Lipids in Cancer, Inflammation and Related Diseases 15th GERLI international Lipidomics meetingWilliam Harvey Day, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Dr Romain Colas poster presentation, Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis
William Harvey DayPrevious event
Banff Inflammation Workshop, Banff, Alberta, Canada, Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotctive and mediate the actions of statins in controlling inflammation Dr Romain Colas presenting Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease Dr Patricia Soares De Souza poster presentation of 13-Series Resolvins Mediate the Leukocyte-Platelet Actions of Atorvastatin and Pravastatin in Inflammatory Arthritis Ms Mary Walker poster presentation of RvT4 Reduces Joint Oedema and Atherosclerosis during Inflammatory Arthritis
Banff Inflammation WorkshopPrevious event
The British Pharmacological Society Pharmacology 2018, London, Dr Patricia Soares De Souza poster presentation of Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
The British Pharmacological Society Pharmacology 2018Previous event
7th European Workshop on Lipid Mediators, Brussels, Dr Jesmond Dalli, giving two presentations: Profiling the resolution metabolome: considerations and methodologies and Functional Lipid Mediator Profiling in Establishing Disease Etiopathogenesis Dr Patricia Soares De Souza presenting the poster Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease Ms Kim Pistorius presenting at the Young Investigator Session PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function Ms Mary Walker presenting at the Young Investigator Session 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
7th European Workshop on Lipid MediatorsPrevious event
Pharmacology 2017, London, Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
Previous event
Bioactive Lipids in Cancer, Inflammation and Related Diseases, Puerto Vallarta, Mexico, Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotective and mediate the actions of statins in controlling inflammation September 2017 UK Life Science and Medicine Summit, Beijing, Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections? September 2017 Eurpoean Shock Society, Paris, Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections? June 2017 World Congress on Inflammation, Solna, Dr Jesmond Dalli presented Immunoresolvants are regulated by the brain and control host responses to infections and tissue regeneration May 2017 Meeting of the Minds, Royal Society, London, Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control January 2017 Biochemical Society, Birmingham, Dr Jesmond Dalli presented Maresin conjugates in tissue regeneration promote the clearance of bacterial infections and are organ protective December 2016 BSI 2016, Liverpool, Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control July 2016 Physiology 2016, Dublin, Dr Jesmond Dalli presented Elucidation of Thirteen Series Resolvins that Regulate Host Responses in Infections June 2016 LBMSDG, London, Dr Jesmond Dalli presented LC-MS/MS Based Structure Elucidation Of Novel Bioactive Mediators And Functional Lipid Mediator Profiling May 2016 BSI London Immunology Showcase, Dr Jesmond Dalli presented Omega-3-fatty acids in inflammatory resolution and organ protection: Specialized Pro-resolving Mediators April 2016 OARSI, Amsterdam, Dr Jesmond Dalli presented Lipid Mediators and the Resolution of Chronic Inflammation: Implications for Arthritis Therapy Prof Jesmond Dalli presented a poster entitled: Identifying neutrophil-derived molecular cues directing innate responses during bacterial infections
7th European Congress of Immunology
Prof Jesmond Dalli co-chaired the Resolution of Inflammation session
International Vascular Biology Meeting 2024
Prof Jesmond Dalli presented a poster entitled: Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease in inflammatory arthritis
9th European Workshop on Lipid Mediators
Dr Duco Koenis presented a poster entitled: Efferocyte-derived MCTRs prime macrophages for continual efferocytosis via Rac1-mediated activation of glycolysis
EFIS-iiSIAR forum Poznan.
Prof Jesmond Dalli presented a talk entitled: MCTRs Regulate Macrophage Pro-resolving and Tissue Reparative Functions
EpiLipidNet Meeting Dresden
Prof Jesmond Dalli presented a talk entitled: A Frameshift Variant in the Maresin 1 Receptor LGR6 Alters Human Phagocyte Responses and Increases Disease Incidence Ms Amitis Saliani presented a poster entitled: Evaluation of different integration and signal to noise algorithms on lipid mediator identification Mr Matthew Dooley presented a poster entitled: Development and validation of a high sensitivity method for the identification and quantitation of specialized pro-resolving mediators and classical eicosanoids.
1st EFIS forum on innate immunity in Sterile Inflammation, Autoimmunity, and their Resolution
Prof Jesmond Dalli presented a talk entitled: Utilizing Pro-Resolving Pathways for Treating Co-Morbidities 20th-23rd of March 2024 2024 European Phagocyte Workshop Prof Jesmond Dalli presented a talk entitled: Apoptotic cell uptake triggers localized MCTR production by macrophages to drive efferocytosis and tissue repair Dr Esteban Gomez presented a talk entitled: A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
CARIM Cardiovascular researcht institute & Maastricht University/University Medical Centre
Prof Jesmond Dalli presented a talk for Cardiovascular Grand Rounds entitled: Resolving cardiovascular diseases – what is the evidence?
Second Meeting of the UK Neutrophil Network
Prof Jesmond Dalli attended the meeting
3rd Resolution Days
Prof Jesmond Dalli presented Insights Into The Biology Of Specialized Pro-resolving Mediators And Their Receptors In Phagocytes Mr Esteban Gomez presented A frame shift mutation in LGR6 Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes and is linked with increased incidence of cardiovascular disease
BIORSP_2023
Prof Jesmond Dalli presented SPM are functional biomarkers for omega-3 supplements
10th Cardiovascular Research Days & 28th Krakow Conference on Endothelium
Prof Jesmond Dalli presented N-3 Docosapentaenoic Acid Resolvins In Vascular Protection
Bioactive Lipids in Cancer, Inflammation and Related Diseases 2022
Prof Jesmond Dalli presented Promoting tissue repair by reprogramming immune cells Mr Esteban A Gomez presented Loss of LGR6 expression as a result of a frameshift mutation alters pro-resolving responses in human phagocytes Ms Roberta De Matteis presented Aspirin Triggered Specialised Pro-Resolving lipid mediators reprogram T cell and macrophage responses in colitis-associated colorectal cancer 9th – 12th of June 2022 31st Nordic Lipidforum Symposium 2022 Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
2022 AOCS Annual Meeting & Expo
Prof Jesmond Dalli presented Structure elucidation and biological evaluations of sulfido-conjugated specialized pro-resolving mediators
10th International Singapore Lipid Symposium
Prof Jesmond Dalli presented Structure elucidation and biological evaluations of n-3 docosapentaenoic acid-derived 13-series Resolvins February 2022 GOED Exchange Prof Jesmond Dalli presented Specialised Pro-resolving Mediators Convey The Immune Regulatory Activities Of Omega-3 Fatty Acids
Ambiotis 15th Anniversary Celebrations
Professor Jesmond Dalli presenting Reprogramming Immune Cells as a Novel Therapeutic Approach
Turkish Pharmacology Society meeting
Professor Jesmond Dalli presenting Resolution of pathways as a novel therapeutic targets in cardiovascular diseases
Lipid Mediators in Brain Diseases Symposium, Hasselt, Belgium
Professor Jesmond Dalli presenting Specialised pro-resolving mediators as modulators of innate and adaptive immunity
ICBL Webinar – Lipid Mediators in Inflammation
Professor Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
ICBL Webinar – Lipid Mediators in InflammationExperimental Biology 2021
Professor Jesmond Dalli presenting Pro-resolving mediators as novel diagnostic and prognostic biomarkers for personalized medicines
The London Metabolomics Network Autumn meeting
Professor Jesmond Dalli presenting Establishing a role for immunoresolvents in the maintenance of homeostasis and as diagnostic markers in patient stratification
The London Metabolomics Network Autumn meetingBioactive Lipids in Cancer, Inflammation and Related Diseases 16th International Conference, St. Petersburg, Florida
Professor Jesmond Dalli presenting Insights mechanisms elicited by immunoresolvants in the maintenance of homeostasis and the termination of inflammation, Tuesday 22 October Dr Romain Colas presenting Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis, Monday 21 October Mr Issa Beegun presenting Maresin 1 regulates peripheral leukocyte responses in patients with chronic eosinophilic nasal polyposis, Monday 21 October Ms Roberta De Matteis presenting Pro-resolving mediators mediate the protective actions of aspirin in colitis associated colorectal cancer, Monday 21 October Dr Patricia Soares De Souza presenting Enriched marine oil supplements increase peripheral blood SPM concentrations and reprogram host immune responses: A randomized double-blind placebo-controlled study, Monday 21 October Mr Esteban Gomez Cifuentes presenting Identification of pro-resolving mediators-based predictive biomarkers to DMARD responsiveness in rheumatoid arthritis, Monday 21 October Dr Duco Koenis presenting RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections, Tuesday 22 October Dr Lucy Ly presenting MCTR1, MCTR2, and MCTR3 resolve inflammation and protect joints in Inflammatory Arthritis, Monday 21 October 30 September – 2 October 2019 15th GERLI international Lipidomics meeting, Compiègne, France
Bioactive Lipids in Cancer, Inflammation and Related Diseases 15th GERLI international Lipidomics meetingWilliam Harvey Day, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
Dr Romain Colas poster presentation, Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis
William Harvey DayPrevious event
Banff Inflammation Workshop, Banff, Alberta, Canada, Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotctive and mediate the actions of statins in controlling inflammation Dr Romain Colas presenting Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease Dr Patricia Soares De Souza poster presentation of 13-Series Resolvins Mediate the Leukocyte-Platelet Actions of Atorvastatin and Pravastatin in Inflammatory Arthritis Ms Mary Walker poster presentation of RvT4 Reduces Joint Oedema and Atherosclerosis during Inflammatory Arthritis
Banff Inflammation WorkshopPrevious event
The British Pharmacological Society Pharmacology 2018, London, Dr Patricia Soares De Souza poster presentation of Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease
The British Pharmacological Society Pharmacology 2018Previous event
7th European Workshop on Lipid Mediators, Brussels, Dr Jesmond Dalli, giving two presentations: Profiling the resolution metabolome: considerations and methodologies and Functional Lipid Mediator Profiling in Establishing Disease Etiopathogenesis Dr Patricia Soares De Souza presenting the poster Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease Ms Kim Pistorius presenting at the Young Investigator Session PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function Ms Mary Walker presenting at the Young Investigator Session 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
7th European Workshop on Lipid MediatorsPrevious event
Pharmacology 2017, London, Ms Kim Pistorius presenting PDn-3 DPA pathway regulates human monocyte differentiation and macrophage function Ms Mary Walker presenting 13-series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis
Previous event
Bioactive Lipids in Cancer, Inflammation and Related Diseases, Puerto Vallarta, Mexico, Dr Jesmond Dalli presenting Novel n-3 docosapentaneoic acid-derived resolvins are vasculoprotective and mediate the actions of statins in controlling inflammation September 2017 UK Life Science and Medicine Summit, Beijing, Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections? September 2017 Eurpoean Shock Society, Paris, Dr Jesmond Dalli, Does Reprogramming The Host Response Using Immunoresolvents Represent A New Paradigm For Treating Infections? June 2017 World Congress on Inflammation, Solna, Dr Jesmond Dalli presented Immunoresolvants are regulated by the brain and control host responses to infections and tissue regeneration May 2017 Meeting of the Minds, Royal Society, London, Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control January 2017 Biochemical Society, Birmingham, Dr Jesmond Dalli presented Maresin conjugates in tissue regeneration promote the clearance of bacterial infections and are organ protective December 2016 BSI 2016, Liverpool, Dr Jesmond Dalli presented ILC-3 and PCTR1 govern tissue resolution status and macrophage responses in infectious inflammation via neuronal control July 2016 Physiology 2016, Dublin, Dr Jesmond Dalli presented Elucidation of Thirteen Series Resolvins that Regulate Host Responses in Infections June 2016 LBMSDG, London, Dr Jesmond Dalli presented LC-MS/MS Based Structure Elucidation Of Novel Bioactive Mediators And Functional Lipid Mediator Profiling May 2016 BSI London Immunology Showcase, Dr Jesmond Dalli presented Omega-3-fatty acids in inflammatory resolution and organ protection: Specialized Pro-resolving Mediators April 2016 OARSI, Amsterdam, Dr Jesmond Dalli presented Lipid Mediators and the Resolution of Chronic Inflammation: Implications for Arthritis Therapy
Prof Jesmond Dalli
Lipid Mediator Unit,
Centre for Biochemical Pharmacology
John Vane Science Centre,
Charterhouse Square,
London, EC1M 6BQ, United Kingdom
Phone: +44 (0) 207 882 8263
Email: j.dalli@qmul.ac.uk
JDALLILAB 